SOURCE: Bollinger Report

February 06, 2012 09:00 ET

A Forward Look, the Year Ahead - Featured Research on Amarin Corporation plc (ADR) and GlaxoSmithKline plc (ADR)

HONG KONG--(Marketwire - Feb 6, 2012) - Today, introduced featured coverage of Amarin Corporation plc (ADR) (NASDAQ: AMRN) and GlaxoSmithKline plc (ADR) (NYSE: GSK). Full research reports are available to readers at:

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experienced in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Bollinger Report screened and selected Amarin Corporation plc (ADR) for its current position within the healthcare industry. Amarin Corporation plc (Amarin) is a clinical-stage biopharmaceutical company focused on developing improved treatments for cardiovascular disease. The Company's development programs capitalize in the field of lipid science and the therapeutic benefits of essential fatty acids in cardiovascular disease. A copy of this report featuring Amarin Corporation plc (ADR) (NASDAQ: AMRN) is available at:

Bollinger Report is featuring GlaxoSmithKline plc (ADR) for its changing role within the healthcare industry. GlaxoSmithKline plc (GSK) is a global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. To download researches and analysis on GlaxoSmithKline plc (ADR) (NYSE: GSK) we welcome investors to visit:

About Bollinger Report
Bollinger Report has come to be known among its peers as a trusted source of information for both investors and technical traders. Our online content is continually updated, bringing fresh new researches and analyses to the investment community.

Contact Information